ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis
ProAdrenomedullin Assessment of Multi-Organ Failure in COvid-19 Sepsis
COVID-19 is a worldwide pandemic. Around 5% of infected patients are admitted in ICU, mainly for respiratory failure. Outcome of these patients is linked to other organ failures. Optimal therapies are not defined so far. The sponsor want to assess the role of MR-ProADM as prognostic biomarker, and the impact of treatments (including supportive treatments) on MOF occurrence and outcome.
Inclusion Criteria:
Exclusion Criteria: